Portfolio company
Regeneron
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops medicines for serious diseases, including eye conditions, cancer and inflammatory disorders, for healthcare providers and global patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genentech
This biotechnology company develops and manufactures medicines for patients with serious diseases including cancer, multiple sclerosis, and respiratory conditions.
Acceleron Pharma
The company develops medicines and vaccines to treat oncology, infectious diseases, and respiratory conditions for patients and healthcare providers.
Iveric Bio
This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.
Dicerna Pharmaceuticals
This biopharmaceutical company develops ribonucleic acid interference therapeutics to treat rare, chronic, and infectious diseases for healthcare providers and global pharmaceutical partners.
Redona Therapeutics
This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.
Hookipa Pharma
This biopharmaceutical company develops arenavirus-based immunotherapies to treat infectious diseases and cancers for patients and healthcare providers.
Amgen
This biotechnology company develops and manufactures biologic medicines to treat patients with serious illnesses, including cancer, kidney disease and inflammatory disorders.
Biogen Idec
This biotechnology company develops therapies for neurological, autoimmune, and hematological disorders for patients and healthcare professionals.
